Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Agrifood Research Finland | UNKNOWN |
| The Finnish Funding Agency for Technology and Innovation | OTHER_GOV |
| Academy of Finland | OTHER |
| University of Oslo |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to investigate the effects of berry consumption on indicators of cardiovascular disease risk (blood pressure, cardiovascular biomarkers, nutrigenomics).
The study has a randomized crossover design. It consists of two 8-wk dietary treatments, with no washout period between periods. The participants are blinded to treatments. The subjects are randomly assigned to either a berry diet or a control diet which they follow for 8 weeks. After that they are crossed over to the other diet for another 8 weeks. The main visits to the study site are at baseline and after 8 and 16 weeks (for blood pressure measurement/ cardiovascular measurements and sample collection). The additional visits are at 4 and 12 wk; these visits are for compliance checks, meeting the study nurse and receiving the study products. The subjects are asked to maintain their normal dietary and lifestyle habits, as well as to keep alcohol intake and physical activity constant during the study.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| berry products | Active Comparator | Berry products |
|
| control products | Placebo Comparator | Control products |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| berry products | Other | effects of berry consumption on cardiovascular indicators two portions daily |
|
| Measure | Description | Time Frame |
|---|---|---|
| Blood pressure | 0, 8 and 16 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| PFA-100 measurement | 0, 8 and 16 weeks | |
| biomarkers of cardiovascular disease risk | 0, 8 and 16 weeks |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Antti Jula, DR. | Finnish Institute for Health and Welfare | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| National Institute for Health and Welfare | Helsinki | Helsinki | 00300 | Finland | ||
| National Institute for Health and Welfare |
Not provided
| ID | Term |
|---|---|
| D007249 | Inflammation |
| ID | Term |
|---|---|
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| OTHER |
Not provided
Not provided
Not provided
Not provided
| control products | Other | two portions daily |
|
| Turku |
| Turku |
| 20720 |
| Finland |